Skip to content

Embryo Development in Microfluidics System of Culture

Comparison of the in Vitro Development of Human Embryos in Static and and Microfluidics Systems of Culture

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01003548
Enrollment
400
Registered
2009-10-28
Start date
2009-10-31
Completion date
2011-10-31
Last updated
2009-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Embryo culture, IVF, Microfluidics, infertility

Brief summary

Embryo culture is a cornerstone of in vitro fertilization treatments. Usually, embryos are cultured in microdrops of culture media in incubators with controlled temperature, humidity and atmosphere. However, these culture systems are static, while in vivo the initial growth of the embryo takes place in the uterine tube and they are submitted to a dynamic environment. The aim of this study is to compare the embryo development on days 2 and 3 of culture morphological features of embryos under static and dynamic(microfluidics) systems of culture.

Detailed description

Embryo culture is a cornerstone of in vitro fertilization treatments. Usually, embryos are cultured in microdrops of culture media in incubators with controlled temperature, humidity and atmosphere. However, these culture systems are static, while in vivo the initial growth of the embryo takes place in the uterine tube and they are submitted to a dynamic environment. The aim of this study is to compare the embryo development on days 2 and 3 of culture morphological features of embryos under static and dynamic(microfluidics) systems of culture.

Interventions

DEVICESMART dynamic system of embryo culture

Embryos will be cultured in a dynamic system of microfluidics.

DEVICEStatic culture

Embryos cultured in 40 microliters microdrops of G-IVF plus series V

Sponsors

Incept Biosystems
CollaboratorUNKNOWN
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 21 and 35 years old * No more than 1 previous IVF failure * Absence of physical conditions that can interfere in oocyte quality * At least 8 zigotes 24 hours after fertilization

Exclusion criteria

* Use of epididimary or testicular sperm * Sperm or egg donation * Untreated systemic diseases

Design outcomes

Primary

MeasureTime frame
Embryo morphology on days 2 and 3 of embryo culture according to the criteria described by Lucinda VeeckEmbryo culture for 3 days before transference to the uterus

Secondary

MeasureTime frame
Implantation rate and pregnancy rate24 month

Countries

Brazil

Contacts

Primary ContactJose R Alegretti, BSc
jalegretti@huntington.com.br551130596113
Backup ContactAndre M Rocha, PhD
arocha@huntington.com.br551130596122

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026